HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
2.580
+0.150 (6.17%)
At close: May 21, 2026, 4:00 PM EDT
2.660
+0.080 (3.10%)
After-hours: May 21, 2026, 7:59 PM EDT
HCW Biologics Employees
HCW Biologics had 36 employees as of December 31, 2024. The number of employees decreased by 9 or -20.00% compared to the previous year.
Employees
36
Change (1Y)
-9
Growth (1Y)
-20.00%
Revenue / Employee
$183,116
Profits / Employee
-$503,273
Market Cap
17.37M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 36 | -9 | -20.00% |
| Dec 31, 2023 | 45 | 1 | 2.27% |
| Dec 31, 2022 | 44 | 0 | - |
| Dec 31, 2021 | 44 | 4 | 10.00% |
| Mar 31, 2021 | 40 | - | - |
| Dec 31, 2020 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| Quince Therapeutics | 38 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| OSR Holdings | 22 |
| SeaStar Medical Holding | 17 |
| IN8bio | 17 |
| NewcelX | 15 |
HCWB News
- 12 hours ago - 3 Penny Stocks to Watch Now, 5/21/26 - TipRanks
- 17 hours ago - HCW Biologics announces pricing of $4M private placement - TheFly
- 17 hours ago - HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 days ago - Why Is Penny Stock HCW Biologics (HCWB) Up Today? - TipRanks
- 7 days ago - HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results - GlobeNewsWire
- 7 days ago - HCW Biologics discovers HCW11-040 prevents bronchopulmonary dysplasia - TheFly
- 7 days ago - HCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies - GlobeNewsWire
- 21 days ago - HCW Biologics Announces Adjournment of Special Meeting of Stockholders Due to Lack of Quorum - GlobeNewsWire